View of Intravenous Levocarnitine Reduces Erythropoiesis-Stimulating Agent Requirements and Improves Anaemia Indices in Maintenance Haemodialysis Patients: A Prospective Cohort Study.

J Muhammad Med Coll

Return to Article Details Intravenous Levocarnitine Reduces Erythropoiesis-Stimulating Agent Requirements and Improves Anaemia Indices in Maintenance Haemodialysis Patients: A Prospective Cohort Study. Download Download PDF